Pfizer & BioNTech Says Its Covid Vax 90.7% Effective In Kids Aged 5-11

Pfizer and BioNTech informed that their Covid-19 vaccine is safe and 90.7 per cent effective against symptomatic coronavirus in children aged 5 to 11.

According to the reports, both the companies revealed the data in a document posted on October 21 which is ahead of the meeting of advisers to the Food and Drug Administration (FDA) scheduled for October 26.

Both the companies- Pfizer and BioNTech are applying FDA emergency use authorization (EUA) of a two-dose regimen of their 10-microgram dose for children of the mentioned age group. The two doses would be administered three weeks apart.

The report further added that as per the data the two-dose primary series of the vaccine given to children from 5 to less than 12 years of age confers a high degree of protective efficacy against Covid-19 during a period when the Delta variant of concern predominates in the US. The FDA’s Vaccines and Related Biological Products Advisory Committee is scheduled to meet on October 26 to discuss whether to authorise the jab.

If the authorization is given then it would be the first Covid-19 vaccine for younger children.